ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,782Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 1942

$458K Total Retail Price of All Prescriptions

Rank: 140 out of 1942

346 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 346 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 8,393 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
FUROSEMIDE 578 543 1 5
LISINOPRIL 506 431 2 2
POTASSIUM CHLORIDE 346 340 3 17
SIMVASTATIN 330 280 4 1
METOPROLOL TARTRATE 327 283 5 9
SERTRALINE HCL 233 213 6 20
AMLODIPINE BESYLATE 222 210 7 6
OMEPRAZOLE 218 182 8 4
LEVOTHYROXINE SODIUM 189 188 9 3
HYDROCHLOROTHIAZIDE 170 148 10 8
JANTOVEN 167 154 11 33
ATENOLOL 162 151 12 7
ALENDRONATE SODIUM 146 116 13 21
LOSARTAN POTASSIUM 128 117 14 18
METFORMIN HCL 126 112 15 10
DONEPEZIL HCL 124 124 16 30
PRAVASTATIN SODIUM 121 121 17 23
FENTANYL 119 82 S2 18 47
GABAPENTIN 111 83 19 16
GLYBURIDE 106 83 R 20 69
RANITIDINE HCL 100 98 21 31
POLYETHYLENE GLYCOL 3350 96 64 22 28
WARFARIN SODIUM 92 79 23 11
CARVEDILOL 88 77 24 39
METOPROLOL SUCCINATE 85 85 25 13
ATORVASTATIN CALCIUM 80 71 26 14
LANTUS 72 47 27 49
NAMENDA 72 72 27 51
DIGOXIN 70 58 29 40
HYDROCODONE-ACETAMINOPHEN 70 54 S3 29 12
TRAMADOL HCL 68 61 31 19
CLOPIDOGREL 67 65 32 55
ALLOPURINOL 67 54 32 26
OXYBUTYNIN CHLORIDE 67 63 32 99
GLIPIZIDE 65 57 35 63
NEXIUM 64 58 36 58
CITALOPRAM HBR 64 64 36 15
MIRTAZAPINE 63 41 38 38
OXYCODONE-ACETAMINOPHEN 63 13 S2 38 56
TERAZOSIN HCL 62 53 40 77
ISOSORBIDE MONONITRATE ER 62 62 40 42
METOLAZONE 61 61 42 145
DIOVAN 61 57 42 44
JANUVIA 60 40 44 85
LIDODERM 54 54 45 98
ACETAMINOPHEN-CODEINE 51 25 S3 46 90
CIPROFLOXACIN HCL 51 46 46 79
PAROXETINE HCL 51 39 46 50
PRAMIPEXOLE DIHYDROCHLORIDE 50 50 49 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.